ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Generation Of Insulin Producing Cells From Pancreatic Tissue With Long Standing Type 1 Diabetes

Y. Garciafigueroa, J. B. Pollett, N. L. Thai, R. Bottino

Imagine Pharma, Pittsburgh, PA

Meeting: 2022 American Transplant Congress

Abstract number: 9030

Keywords: Insulin, Islets, Pancreas, Proliferation

Topic: Clinical Science » Pancreas » 65 - Pancreas and Islet: All Topics

Session Information

Session Name: Late Breaking: Basic / Translational

Session Type: Rapid Fire Oral Abstract

Date: Monday, June 6, 2022

Session Time: 3:30pm-5:00pm

 Presentation Time: 4:50pm-5:00pm

Location: Hynes Room 313

*Purpose: AIPCs (Activated Islet Proliferating Cells), are a novel cell population from isolated human islets obtained using a simple culture protocol that can generate cells secreting both insulin and glucagon in response to secretagogues. Furthermore, AIPCs form Dithizone-positive islet-like cell clusters that respond to glucose stimulation and may represent de novo islets. When IV injected, AIPCs home and engraft in the pancreas and release insulin, and represent a viable option for cell transplantation for the treatment of diabetes. Herein we report the isolation of AIPCs from a biopsy from a patient with long-standing type 1 diabetes (56 years after diagnosis), and the generation of insulin secreting cells from non-insulin secreting pancreatic tissue.

*Methods: Biopsies of 1x1mm3 were obtained from the pancreas of a deceased organ donor with long standing (56 yrs) diabetes. Pancreas cold ischemia time was 9 hours and the organ was preserved in University of Wisconsin solution on ice. The biopsies were freshly cultured in the presence of culture medium containing IMG-i (a proprietary sequence) at 37ºC, 5% CO2.

*Results: After 12-15 days bioptic-derived cells were mobilized and began to adhere to the dish and to proliferate. During the subsequent 4-6 weeks, the adherent cells continued to proliferate, became confluent and kept multiplying, doubling every 3 days. Type 1 diabetes-derived AIPCs exhibited morphological similarities to AIPCs obtained from non-diabetic donors. Similarly, they formed islet-like cell clusters with size consistent with that of islets of Langerhans. Following glucose stimulation, secreted insulin was detected in the culture medium. Microarray mRNA profile of the cells confirmed gene profile compatible with a pancreatic endocrine islet cell population, with expression of insulin, and glucagon. Furthermore, these type 1 diabetes-derived AIPCs also expressed the pancreatic transcription factors PDX1, Nkx6, ngn3, NeuroD, and MafA and MafB, as well as the islet neogenesis factor nestin, the glucose transporter Glut-2, the secretory product of β-cells IAPP, and somatostatin which, is secreted by islet δ-cells. These findings suggest the ability of type 1 diabetes- derived AIPCs to generate insulin producing cells and carry all factors necessary for islet neogenesis.

*Conclusions: This study demonstrates that insulin producing cells can be obtained from culturing pancreatic biopsies from organ donors with long standing type 1 diabetes. This study provides the ground work and approach for the generation and treatment of type 1 diabetes in the setting of an autologous cell transplantation.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Garciafigueroa Y, Pollett JB, Thai NL, Bottino R. Generation Of Insulin Producing Cells From Pancreatic Tissue With Long Standing Type 1 Diabetes [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/generation-of-insulin-producing-cells-from-pancreatic-tissue-with-long-standing-type-1-diabetes/. Accessed May 28, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences